{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:16:18Z","timestamp":1740122178080,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10620-019-05775-4","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T07:02:55Z","timestamp":1565593375000},"page":"2736-2739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bone of Contention: Helicobacter pylori and Osteoporosis\u2014Is There an Association?"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1497-0254","authenticated-orcid":false,"given":"Konstantinos","family":"Papamichael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garyfallia","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcy A.","family":"Cheifetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"Cheifetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"5775_CR1","first-page":"659","volume":"23","author":"H Huang","year":"2018","unstructured":"Huang H, Tian J, Xu X, et al. A study on the roles of Helicobacter pylori in bile reflux gastritis and gastric cancer. J BUON. 2018;23:659\u2013664.","journal-title":"J BUON"},{"key":"5775_CR2","first-page":"290","volume":"31","author":"F Perri","year":"1999","unstructured":"Perri F, Clemente R, Festa V, et al. A Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol. 1999;31:290\u2013294.","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"5775_CR3","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3748\/wjg.15.2701","volume":"15","author":"KX Papamichael","year":"2009","unstructured":"Papamichael KX, Papaioannou G, Karga H, et al. Helicobacter pylori infection and endocrine disorders: Is there a link? World J Gastroenterol. 2009;15:2701\u20132707.","journal-title":"World J Gastroenterol"},{"key":"5775_CR4","first-page":"593","volume":"9","author":"KM Sidlauskas","year":"2014","unstructured":"Sidlauskas KM, Sutton EE, Biddle MA. Osteoporosis in men: Epidemiology and treatment with denosumab. Clin Interv Aging. 2014;9:593\u2013601.","journal-title":"Clin Interv Aging"},{"key":"5775_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.berh.2014.07.005","volume":"28","author":"R Milte","year":"2014","unstructured":"Milte R, Crotty M. Musculoskeletal health, frailty and functional decline. Best Pract Res Clin Rheumatol. 2014;28:395\u2013410.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5775_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1359\/JBMR.040103","volume":"19","author":"SL Ferrari","year":"2004","unstructured":"Ferrari SL, Karasik D, Liu J, et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study. J Bone Miner Res. 2004;19:552\u2013559.","journal-title":"J Bone Miner Res"},{"key":"5775_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10038-003-0020-8","volume":"48","author":"HW Chung","year":"2003","unstructured":"Chung HW, Seo JS, Hur SE, et al. Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet. 2003;48:243\u2013248.","journal-title":"J Hum Genet"},{"issue":"1","key":"5775_CR8","doi-asserted-by":"publisher","first-page":"8666","DOI":"10.1038\/s41598-017-09080-w","volume":"7","author":"JV Huang","year":"2017","unstructured":"Huang JV, Schooling CM. Inflammation and bone mineral density: A Mendelian randomization study. Sci Rep. 2017;7:8666.","journal-title":"Sci Rep"},{"key":"5775_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10620-008-0417-5","volume":"54","author":"AM Kakehasi","year":"2009","unstructured":"Kakehasi AM, Rodrigues CB, Carvalho AV, et al. Chronic gastritis and bone mineral density in women. Dig Dis Sci. 2009;54:819\u2013824.","journal-title":"Dig Dis Sci"},{"key":"5775_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/BOR.0000000000000291","volume":"28","author":"BN Andersen","year":"2016","unstructured":"Andersen BN, Johansen PB, Abrahamsen B. Proton pump inhibitors and osteoporosis. Curr Opin Rheumatol. 2016;28:420\u2013425.","journal-title":"Curr Opin Rheumatol"},{"key":"5775_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10620-005-2651-4","volume":"50","author":"N Figura","year":"2005","unstructured":"Figura N, Gennari L, Merlotti D, et al. Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci. 2005;50:847\u2013852.","journal-title":"Dig Dis Sci"},{"key":"5775_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00774-015-0688-9","volume":"34","author":"MR Kalantarhormozi","year":"2016","unstructured":"Kalantarhormozi MR, Assadi M, Vahdat K, et al. Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: A prospective cohort study. J Bone Miner Metab. 2016;34:422\u2013428.","journal-title":"J Bone Miner Metab"},{"key":"5775_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1590\/S0004-28032007000300016","volume":"44","author":"AM Kakehasi","year":"2007","unstructured":"Kakehasi AM, Mendes CM, Coelho LG, et al. The presence of Helicobacter pylori in postmenopausal women is not a factor to the decrease of bone mineral density. Arq Gastroenterol. 2007;44:266\u2013270.","journal-title":"Arq Gastroenterol"},{"key":"5775_CR14","first-page":"62","volume":"6","author":"M Fotouk-Kiai","year":"2015","unstructured":"Fotouk-Kiai M, Hoseini SR, Meftah N, et al. Relationship between Helicobacter pylori infection (Hp) and bone mineral density (BMD) in elderly people. Casp J Intern Med. 2015;6:62\u201366.","journal-title":"Casp J Intern Med"},{"key":"5775_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000479317","volume":"96","author":"D Chinda","year":"2017","unstructured":"Chinda D, Shimoyama T, Iino C, et al. Decrease of estradiol and several lifestyle factors, but not Helicobacter pylori infection, are significant risks for osteopenia in Japanese females. Digestion. 2017;96:103\u2013109.","journal-title":"Digestion"},{"key":"5775_CR16","first-page":"e39662","volume":"15","author":"B Heidari","year":"2017","unstructured":"Heidari B, Muhammadi A, Javadian Y, et al. Associated factors of bone mineral density and osteoporosis in elderly males. Int J Endocrinol Metab. 2017;15:e39662.","journal-title":"Int J Endocrinol Metab"},{"key":"5775_CR17","first-page":"7410801","volume":"2018","author":"LJ Lu","year":"2018","unstructured":"Lu LJ, Hao NB, Liu JJ, et al. Correlation between Helicobacter pylori infection and metabolic abnormality in general population: A cross-sectional study. Gastroenterol Res Pract. 2018;2018:7410801.","journal-title":"Gastroenterol Res Pract"},{"key":"5775_CR18","doi-asserted-by":"publisher","first-page":"340765","DOI":"10.1155\/2014\/340765","volume":"2014","author":"D Asaoka","year":"2014","unstructured":"Asaoka D, Nagahara A, Hojo M, et al. The relationship between H. pylori infection and osteoporosis in Japan. Gastroenterol Res Pract. 2014;2014:340765.","journal-title":"Gastroenterol Res Pract"},{"key":"5775_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4082\/kjfm.2015.36.5.239","volume":"36","author":"YH Chung","year":"2015","unstructured":"Chung YH, Gwak JS, Hong SW, et al. Helicobacter pylori: A possible risk factor for bone health. Korean J Fam Med. 2015;36:239\u2013244.","journal-title":"Korean J Fam Med"},{"key":"5775_CR20","doi-asserted-by":"publisher","first-page":"e0175365","DOI":"10.1371\/journal.pone.0175365","volume":"12","author":"LW Chen","year":"2017","unstructured":"Chen LW, Chen FP, Hsieh CW, et al. Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study. PLoS ONE. 2017;12:e0175365.","journal-title":"PLoS ONE"},{"key":"5775_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2147\/TCRM.S80647","volume":"11","author":"D Asaoka","year":"2015","unstructured":"Asaoka D, Nagahara A, Shimada Y, et al. Risk factors for osteoporosis in Japan: Is it associated with Helicobacter pylori? Ther Clin Risk Manag. 2015;11:381\u2013391.","journal-title":"Ther Clin Risk Manag"},{"key":"5775_CR22","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10620-015-3576-1","volume":"60","author":"S Mizuno","year":"2015","unstructured":"Mizuno S, Matsui D, Watanabe I, et al. Serologically determined gastric mucosal condition is a predictive factor for osteoporosis in Japanese men. Dig Dis Sci. 2015;60:2063\u20132069.","journal-title":"Dig Dis Sci"},{"key":"5775_CR23","first-page":"814756","volume":"2014","author":"SC Lin","year":"2014","unstructured":"Lin SC, Koo M, Tsai KW. Association between Helicobacter pylori infection and risk of osteoporosis in elderly Taiwanese women with upper gastrointestinal diseases: A retrospective patient record review. Gastroenterol Res Pract. 2014;2014:814756.","journal-title":"Gastroenterol Res Pract"},{"key":"5775_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12876-018-0780-4","volume":"18","author":"BL Pan","year":"2018","unstructured":"Pan BL, Huang CF, Chuah SK, et al. Relationship between Helicobacter pylori infection and bone mineral density: A retrospective cross-sectional study. BMC Gastroenterol. 2018;18:54.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"5775_CR25","doi-asserted-by":"crossref","first-page":"155798831984821","DOI":"10.1177\/1557988319848219","volume":"13","author":"D Chinda","year":"2019","unstructured":"Chinda D, Shimoyama T, Sawada K, et al. Lifestyle factors rather than Helicobacter pylori infection or estradiol level are associated with osteopenia in Japanese men. Am J Mens Health. 2019;13:1557988319848219.","journal-title":"Am J Mens Health"},{"key":"5775_CR26","doi-asserted-by":"publisher","first-page":"e0162645","DOI":"10.1371\/journal.pone.0162645","volume":"11","author":"HM Shih","year":"2016","unstructured":"Shih HM, Hsu TY, Chen CY. Analysis of patients with Helicobacter pylori infection and the subsequent risk of developing osteoporosis after eradication therapy: A nationwide population-based cohort study. PLoS ONE. 2016;11:e0162645.","journal-title":"PLoS ONE"},{"key":"5775_CR27","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/gut.35.11.1567","volume":"35","author":"S Moss","year":"1994","unstructured":"Moss S, Legon S, Davies J, Calam J. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut. 1994;35:1567\u20131570.","journal-title":"Gut"},{"key":"5775_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1523-5378.2007.00563.x","volume":"12","author":"T Rokkas","year":"2007","unstructured":"Rokkas T, Pistiolas D, Sechopoulos P, et al. The long-term impact of Helicobacter pylori eradication on gastric histology: A systematic review and meta-analysis. Helicobacter. 2007;12:32\u201338.","journal-title":"Helicobacter"},{"key":"5775_CR29","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00774-015-0703-1","volume":"34","author":"S Upala","year":"2016","unstructured":"Upala S, Sanguankeo A, Wijarnpreecha K, Jaruvongvanich V. Association between Helicobacter pylori infection and osteoporosis: A systematic review and meta-analysis. J Bone Miner Metab. 2016;34:482\u2013483.","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"5775_CR30","doi-asserted-by":"publisher","first-page":"e027356","DOI":"10.1136\/bmjopen-2018-027356","volume":"9","author":"T Wang","year":"2019","unstructured":"Wang T, Li X, Zhang Q, et al. Relationship between Helicobacter pylori infection and osteoporosis: A systematic review and meta-analysis. BMJ Open. 2019;9:e027356.","journal-title":"BMJ Open"},{"key":"5775_CR31","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1210\/jc.2010-2135","volume":"96","author":"SP Bours","year":"2011","unstructured":"Bours SP, van Geel TA, Geusens PP, et al. Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J Clin Endocrinol Metab. 2011;96:1360\u20131367.","journal-title":"J Clin Endocrinol Metab"},{"key":"5775_CR32","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"NE Lane","year":"2006","unstructured":"Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194:S3\u2013S11.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05775-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05775-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05775-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T23:09:02Z","timestamp":1597100942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05775-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["5775"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05775-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"26 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"A.S.C has received consulting fees from Abbvie, Janssen, Takeda Pfizer, Amag, and Arena and research support from Miraca. K.P. has received a lecture fee from Mitsubishi Tanabe Pharma. The remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}